-DOCSTART- -X- O
Cough -X- _ O
etiquette -X- _ O
and -X- _ O
respiratory -X- _ O
hygiene -X- _ O
are -X- _ O
forms -X- _ O
of -X- _ O
source -X- _ O
control -X- _ O
encouraged -X- _ O
to -X- _ O
prevent -X- _ O
the -X- _ O
spread -X- _ O
of -X- _ O
respiratory -X- _ O
infection. -X- _ O
The -X- _ O
use -X- _ O
of -X- _ O
surgical -X- _ B-Intervention
masks -X- _ I-Intervention
as -X- _ O
a -X- _ O
means -X- _ O
of -X- _ O
source -X- _ O
control -X- _ O
has -X- _ O
not -X- _ O
been -X- _ O
quantified -X- _ O
in -X- _ O
terms -X- _ O
of -X- _ O
reducing -X- _ O
exposure -X- _ O
to -X- _ O
others. -X- _ O
We -X- _ O
designed -X- _ O
an -X- _ O
in -X- _ O
vitro -X- _ O
model -X- _ O
using -X- _ O
various -X- _ O
facepieces -X- _ B-Intervention
to -X- _ O
assess -X- _ O
their -X- _ O
contribution -X- _ O
to -X- _ O
exposure -X- _ O
reduction -X- _ O
when -X- _ O
worn -X- _ O
at -X- _ O
the -X- _ O
infectious -X- _ B-Patient
source -X- _ I-Patient
( -X- _ I-Patient
Source -X- _ I-Patient
) -X- _ I-Patient
relative -X- _ O
to -X- _ O
facepieces -X- _ B-Intervention
worn -X- _ O
for -X- _ O
primary -X- _ O
( -X- _ O
Receiver -X- _ O
) -X- _ O
protection -X- _ O
, -X- _ O
and -X- _ O
the -X- _ O
factors -X- _ O
that -X- _ O
contribute -X- _ O
to -X- _ O
each. -X- _ O
In -X- _ O
a -X- _ O
chamber -X- _ O
with -X- _ O
various -X- _ O
airflows -X- _ O
, -X- _ O
radiolabeled -X- _ O
aerosols -X- _ O
were -X- _ O
exhaled -X- _ O
via -X- _ O
a -X- _ O
ventilated -X- _ O
soft-face -X- _ O
manikin -X- _ O
head -X- _ O
using -X- _ O
tidal -X- _ O
breathing -X- _ O
and -X- _ O
cough -X- _ O
( -X- _ O
Source -X- _ O
) -X- _ O
. -X- _ O
Another -X- _ O
manikin -X- _ O
, -X- _ O
containing -X- _ O
a -X- _ O
filter -X- _ O
, -X- _ O
quantified -X- _ O
recipient -X- _ O
exposure -X- _ O
( -X- _ O
Receiver -X- _ O
) -X- _ O
. -X- _ O
The -X- _ O
natural -X- _ B-Intervention
fit -X- _ I-Intervention
surgical -X- _ I-Intervention
mask -X- _ I-Intervention
, -X- _ I-Intervention
fitted -X- _ I-Intervention
( -X- _ I-Intervention
SecureFit -X- _ I-Intervention
) -X- _ I-Intervention
surgical -X- _ I-Intervention
mask -X- _ I-Intervention
and -X- _ I-Intervention
an -X- _ I-Intervention
N95-class -X- _ I-Intervention
filtering -X- _ I-Intervention
facepiece -X- _ I-Intervention
respirator -X- _ I-Intervention
( -X- _ I-Intervention
commonly -X- _ I-Intervention
known -X- _ I-Intervention
as -X- _ I-Intervention
an -X- _ I-Intervention
“N95 -X- _ I-Intervention
respirator” -X- _ I-Intervention
) -X- _ I-Intervention
with -X- _ I-Intervention
and -X- _ I-Intervention
without -X- _ I-Intervention
a -X- _ I-Intervention
Vaseline-seal -X- _ I-Intervention
were -X- _ I-Intervention
tested. -X- _ I-Intervention
With -X- _ O
cough -X- _ O
, -X- _ O
source -X- _ O
control -X- _ O
( -X- _ O
mask -X- _ O
or -X- _ O
respirator -X- _ O
on -X- _ O
Source -X- _ O
) -X- _ O
was -X- _ O
statistically -X- _ O
superior -X- _ O
to -X- _ O
mask -X- _ O
or -X- _ O
unsealed -X- _ O
respirator -X- _ O
protection -X- _ O
on -X- _ O
the -X- _ O
Receiver -X- _ O
( -X- _ O
Receiver -X- _ O
protection -X- _ O
) -X- _ O
in -X- _ O
all -X- _ O
environments. -X- _ O
To -X- _ O
equal -X- _ O
source -X- _ O
control -X- _ O
during -X- _ O
coughing -X- _ O
, -X- _ O
the -X- _ O
N95 -X- _ B-Intervention
respirator -X- _ I-Intervention
must -X- _ O
be -X- _ O
Vaseline-sealed. -X- _ O
During -X- _ O
tidal -X- _ O
breathing -X- _ O
, -X- _ O
source -X- _ O
control -X- _ O
was -X- _ O
comparable -X- _ O
or -X- _ O
superior -X- _ O
to -X- _ O
mask -X- _ O
or -X- _ O
respirator -X- _ O
protection -X- _ O
on -X- _ O
the -X- _ O
Receiver. -X- _ O
Source -X- _ B-Outcome
control -X- _ I-Outcome
via -X- _ I-Outcome
surgical -X- _ I-Outcome
masks -X- _ I-Outcome
may -X- _ I-Outcome
be -X- _ I-Outcome
an -X- _ I-Outcome
important -X- _ I-Outcome
adjunct -X- _ I-Outcome
defense -X- _ I-Outcome
against -X- _ I-Outcome
the -X- _ I-Outcome
spread -X- _ I-Outcome
of -X- _ I-Outcome
respiratory -X- _ I-Outcome
infections. -X- _ I-Outcome
The -X- _ O
fit -X- _ B-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
mask -X- _ I-Outcome
or -X- _ I-Outcome
respirator -X- _ I-Outcome
, -X- _ I-Outcome
in -X- _ I-Outcome
combination -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
airflow -X- _ I-Outcome
patterns -X- _ I-Outcome
in -X- _ I-Outcome
a -X- _ I-Outcome
given -X- _ I-Outcome
setting -X- _ I-Outcome
, -X- _ I-Outcome
are -X- _ I-Outcome
significant -X- _ I-Outcome
contributors -X- _ I-Outcome
to -X- _ I-Outcome
source -X- _ I-Outcome
control -X- _ I-Outcome
efficacy. -X- _ I-Outcome
Future -X- _ O
clinical -X- _ O
trials -X- _ O
should -X- _ O
include -X- _ O
a -X- _ O
surgical -X- _ O
mask -X- _ O
source -X- _ O
control -X- _ O
arm -X- _ O
to -X- _ O
assess -X- _ O
the -X- _ O
contribution -X- _ O
of -X- _ O
source -X- _ O
control -X- _ O
in -X- _ O
overall -X- _ O
protection -X- _ O
against -X- _ O
airborne -X- _ O
infection -X- _ O
. -X- _ O

